Paiardini Mirko, Frank Ian, Pandrea Ivona, Apetrei Cristian, Silvestri Guido
Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, USA.
AIDS Rev. 2008 Jan-Mar;10(1):36-46.
The mucosal immune system plays a central role in both the transmission of HIV infection and the pathogenesis of AIDS. Most HIV infections are acquired through mucosal transmission, and quantitative and qualitative defects of mucosal immunity are consistently present in all stages of pathogenic HIV and SIV infections. A series of recent studies has emphasized the role of a rapid, dramatic, and largely irreversible depletion of mucosa-associated lymphoid tissue-based memory CD4(+)CCR5(+) T-cells as a key determinant of disease progression in HIV-infected individuals and SIV-infected macaques. It has also been proposed that, in order to be effective, an AIDS vaccine should prevent the early depletion of these mucosal CD4(+) T-cells. However, the observation of depletion of mucosal CD4(+) T-cells during the primary phase of nonpathogenic SIV infection of natural SIV hosts, such as sooty mangabeys and African green monkeys, suggests that additional pathogenic factors are involved in the AIDS-associated mucosal immune dysfunction. These factors may include: (i) selective depletion of specific CD4(+) T-cell subsets; (ii) dysfunction of other (non-CD4(+)) immune cells; and (iii) generalized immune activation. Importantly, the mucosal immune dysfunction observed during pathogenic HIV and SIV infection is associated with translocation of microbial products (i.e. lipopolysaccharide) from the intestinal lumen to the systemic circulation where they may be responsible, at least in part, for the chronic immune activation that follows pathogenic HIV and SIV infections. The role of mucosal immunity in AIDS pathogenesis emphasizes the importance of understanding whether and to what extent the HIV-associated depletion of mucosal CD4(+) T-cells is reversible after prolonged suppression of virus replication with antiretroviral therapy. Further studies of mucosal immunity during primate lentiviral infections will be needed to better understand, and ultimately prevent and treat, the mechanisms underlying the AIDS-associated mucosal immune dysfunction.
黏膜免疫系统在HIV感染传播及艾滋病发病机制中均发挥着核心作用。多数HIV感染是通过黏膜传播获得的,在致病性HIV和SIV感染的各个阶段均持续存在黏膜免疫的定量和定性缺陷。一系列近期研究强调,基于黏膜相关淋巴组织的记忆性CD4(+)CCR5(+) T细胞迅速、显著且在很大程度上不可逆的耗竭,是HIV感染个体和SIV感染猕猴疾病进展的关键决定因素。也有人提出,为有效起见,艾滋病疫苗应防止这些黏膜CD4(+) T细胞的早期耗竭。然而,在自然SIV宿主(如乌黑白眉猴和非洲绿猴)的非致病性SIV感染初期观察到黏膜CD4(+) T细胞的耗竭,这表明艾滋病相关的黏膜免疫功能障碍还涉及其他致病因素。这些因素可能包括:(i) 特定CD4(+) T细胞亚群的选择性耗竭;(ii) 其他(非CD4(+))免疫细胞的功能障碍;以及(iii) 全身性免疫激活。重要的是,在致病性HIV和SIV感染期间观察到的黏膜免疫功能障碍与微生物产物(即脂多糖)从肠腔向体循环的移位有关,在体循环中它们可能至少部分导致致病性HIV和SIV感染后的慢性免疫激活。黏膜免疫在艾滋病发病机制中的作用强调了了解在通过抗逆转录病毒疗法长期抑制病毒复制后,HIV相关的黏膜CD4(+) T细胞耗竭是否以及在何种程度上可逆的重要性。需要对灵长类慢病毒感染期间的黏膜免疫进行进一步研究,以更好地理解并最终预防和治疗艾滋病相关黏膜免疫功能障碍的潜在机制。